Encube Ethicals is an integrated pharmaceutical company with over 23 years of experience in contract development and manufacturing, specializing in topical formulations. The company is renowned for its manufacturing facility in Madkaim - Goa, India, recognized as the largest single-site topical manufacturing facility globally. Focused on prescription and OTC pharmaceuticals, as well as cosmetic semisolid dosage forms, Encube prides itself on its commitment to excellence.
Established in 1995, Encube's R&D Centre in Mumbai, India houses a specialized team of over 150 scientists dedicated to formulating topical products. The company's dedication to research and development underscores its commitment to innovation and pushing industry boundaries.
The most recent milestone in Encube Ethicals' journey was the Private Equity Round investment announced on 28 June 2021. Notably, this round saw investment participation from Quadria Capital and Gulf Islamic Investments LLC (GII). This investment not only strengthens the company's financial standing but also signifies the confidence and support from prominent investors in the industry.
Encube Ethicals, with its specialized focus on topical formulations and its recent investment backing, is poised to reinforce its position as a leading player in the pharmaceutical manufacturing industry, with potential for further expansion and innovation.
No recent news or press coverage available for Encube Ethicals.